Metabolic Syndrome Pipeline Review, H2 2012 New Report
Metabolic Syndrome - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Metabolic Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metabolic Syndrome.
View full press release